跳至主要内容
临床试验/JPRN-UMIN000019874
JPRN-UMIN000019874已完成未知

The Effect of Rsedronate and Denosumab on Periprosthetic Bone Remodeling Following Total Hip Arthroplasty - Prevention of stress shielding with risedoronate and denosumab

Shonan Kamakura Joint Reconstruction Center0 个研究点目标入组 100 人开始时间: 2015年11月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) oral Bisphosphonate therapy for more than 3 years 2) oral Bisphosphonate therapy within 6 months prior to the study enrollment 3) oral Bisphosphonate therapy for more than 2 weeks between 6 months and 3 years prior to the study enrollment 4) intravenous Bisphosphonate therapy within 5 years prior to the study enrollment 5) Parathyroid hormone therapy within 6 weeks prior to the study enrollment 6) A history of Osteotomy 7) sever renal dysfunction (GFR< 30) 8) sever liver dysfunction 9) malignant tumor 10) hypocalcemia, hypokalemia 11) A history ofesophagostenosis, esophageal achalasia 12) A history of hyperparathyroidism 13) glucocorticoids therapy 14) pregnant woman 15) The patients should be excluded, who have poor medical compliance, drug-induced allergy, etc.

研究者

相似试验

进行中(未招募)
不适用
A study in postmenopausal women with severe osteoporosis to compare the effects of two osteoporosis drugs (Teriparatide and Risedronate) on fractures of the spine
EUCTR2012-000123-41-DEEli Lilly and Company Limited1,340
进行中(未招募)
1 期
A study in postmenopausal women with severe osteoporosis to compare the effects of two osteoporosis drugs (Teriparatide and Risedronate) on fractures of the spine
EUCTR2012-000123-41-ESilly S.A.1,340
进行中(未招募)
1 期
A study in postmenopausal women with severe osteoporosis to compare the effects of two osteoporosis drugs (Teriparatide and Risedronate) on fractures of the spinePostmenopausal women with established osteoporosis and at least two moderate or one severe prevalent fragility fracture.MedDRA version: 16.1Level: LLTClassification code 10031288Term: Osteoporosis with fractureSystem Organ Class: 100000004859
EUCTR2012-000123-41-ATEli Lilly and Company Limited1,340
进行中(未招募)
1 期
A study in postmenopausal women with severe osteoporosis to compare the effects of two osteoporosis drugs (Teriparatide and Risedronate) on fractures of the spinePostmenopausal women with established osteoporosis and at least two moderate or one severe prevalent fragility fracture.MedDRA version: 15.0Level: LLTClassification code 10031288Term: Osteoporosis with fractureSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2012-000123-41-ITELI LILLY1,340
进行中(未招募)
1 期
A study in postmenopausal women with severe osteoporosis to compare the effects of two osteoporosis drugs (Teriparatide and Risedronate) on fractures of the spinePostmenopausal women with established osteoporosis and at least two moderate or one severe prevalent fragility fracture.MedDRA version: 16.0Level: LLTClassification code 10031288Term: Osteoporosis with fractureSystem Organ Class: 100000004859
EUCTR2012-000123-41-HUEli Lilly and Company Limited1,340